PMID- 31783404 OWN - NLM STAT- MEDLINE DCOM- 20210517 LR - 20210517 IS - 1876-4479 (Electronic) IS - 1873-9946 (Linking) VI - 14 IP - 6 DP - 2020 Jul 9 TI - Zinc Deficiency Activates the IL-23/Th17 Axis to Aggravate Experimental Colitis in Mice. PG - 856-866 LID - 10.1093/ecco-jcc/jjz193 [doi] AB - BACKGROUND AND AIMS: Patients with inflammatory bowel disease [IBD], especially Crohn's disease, often develop zinc deficiency. However, the precise mechanisms by which zinc deficiency affects IBD pathology, particularly intestinal macrophage function, remain unclear. We studied the effects of zinc deficiency on the development and progression of colitis in mice. METHODS: To induce colitis, mice were treated with 2,4,6-trinitrobenzene sulphonic acid. Rag1-/- mice were then given injections of naive CD4+CD62L+ T cells. The respective degrees of mucosal injury of mice that had received a zinc chelator (TPEN; N,N,N',N'-tetrakis [2-pyridylmethyl]ethylenediamine) and of control mice were subsequently compared. Colonic lamina propria mononuclear cells were isolated by enzymatic digestion and were examined using flow cytometry. To generate mouse bone marrow-derived macrophages [BMDMs], bone marrow cells were stimulated with mouse macrophage-colony stimulating factor. RESULTS: Zinc deficiency aggravates colonic inflammation through the activation of type 17 helper T [Th17] cells in mice. Flow cytometric analysis revealed that zinc deficiency significantly increases the proportion of pro-inflammatory [M1] macrophages in colonic lamina propria mononuclear cells obtained from inflamed colon. Interferon-gamma plus lipopolysaccharide-mediated M1 skewing alters the expression of zinc transporters in BMDMs and thereby decreases the intracellular free zinc. TPEN treatment mimicking the effects of the M1 skewing up-regulates IL-23p19 expression, which is strongly related to Th17 development. Furthermore, the nuclear accumulation of interferon-regulatory factor 5 is closely involved in IL-23p19 induction in zinc-deficient macrophages. CONCLUSIONS: Zinc deficiency aggravates colonic inflammation through activation of the IL-23/Th17 axis. This activation is controlled by subcellular distribution of interferon-regulatory factor 5. CI - Copyright (c) 2019 European Crohn's and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com. FAU - Higashimura, Yasuki AU - Higashimura Y AD - Department of Food Science, Ishikawa Prefectural University, Nonoichi, Ishikawa, Japan. FAU - Takagi, Tomohisa AU - Takagi T AD - Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan. AD - Department for Medical Innovation and Translational Medical Science, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan. FAU - Naito, Yuji AU - Naito Y AD - Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan. FAU - Uchiyama, Kazuhiko AU - Uchiyama K AD - Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan. FAU - Mizushima, Katsura AU - Mizushima K AD - Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan. FAU - Tanaka, Makoto AU - Tanaka M AD - Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan. FAU - Hamaguchi, Masahide AU - Hamaguchi M AD - Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan. FAU - Itoh, Yoshito AU - Itoh Y AD - Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan. LA - eng PT - Journal Article PL - England TA - J Crohns Colitis JT - Journal of Crohn's & colitis JID - 101318676 RN - 0 (Carrier Proteins) RN - 0 (Chelating Agents) RN - 0 (Ethylenediamines) RN - 0 (Interleukin-23) RN - 0 (Trace Elements) RN - 0 (zinc-binding protein) RN - J41CSQ7QDS (Zinc) RN - R9PTU1U29I (N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine) SB - IM MH - Animals MH - Carrier Proteins/metabolism MH - Chelating Agents/pharmacology MH - Deficiency Diseases/immunology MH - Disease Models, Animal MH - Disease Progression MH - Ethylenediamines/pharmacology MH - *Inflammatory Bowel Diseases/immunology/metabolism/pathology MH - Interleukin-23/immunology MH - *Intestinal Mucosa/immunology/pathology MH - *Macrophages/immunology/metabolism MH - Mice MH - Th17 Cells/immunology MH - Trace Elements/deficiency/immunology/metabolism MH - *Zinc/deficiency/immunology/metabolism OTO - NOTNLM OT - Inflammatory bowel disease OT - lymphocytes OT - macrophages EDAT- 2019/11/30 06:00 MHDA- 2021/05/18 06:00 CRDT- 2019/11/30 06:00 PHST- 2019/11/30 06:00 [pubmed] PHST- 2021/05/18 06:00 [medline] PHST- 2019/11/30 06:00 [entrez] AID - 5648054 [pii] AID - 10.1093/ecco-jcc/jjz193 [doi] PST - ppublish SO - J Crohns Colitis. 2020 Jul 9;14(6):856-866. doi: 10.1093/ecco-jcc/jjz193.